Form 8-K

8-K — Dolby Laboratories, Inc.

Accession: 0001193125-26-197338

Filed: 2026-04-30

Period: 2026-04-30

CIK: 0001308547

SIC: 6794 (PATENT OWNERS & LESSORS)

Item: Results of Operations and Financial Condition

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — d16309d8k.htm (Primary)

EX-99.1 (d16309dex991.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: d16309d8k.htm · Sequence: 1

8-K

false 0001308547 0001308547 2026-04-30 2026-04-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

April 30, 2026

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-32431

90-0199783

(State or other jurisdiction of

incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Class A common stock, $0.001 par value

DLB

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Section 2 - Financial Information

ITEM 2.02

Results of Operations and Financial Condition.

The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On April 30, 2026, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended March 27, 2026. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

Section 8 – Other Events

ITEM 8.01

Other Events

Declaration of Dividend

On April 30, 2026, the Company announced a cash dividend of $0.36 per share of Class A and Class B Common Stock, payable on May 20, 2026 to stockholders of record as of the close of business on May 12, 2026.

Disclosure Channels to Disseminate Information

The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

Section 9 - Financial Statements and Exhibits

ITEM 9.01

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

No.

Description

99.1

Press Release of Dolby Laboratories, Inc. dated April 30, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOLBY LABORATORIES, INC.

By:

/s/ Robert Park

Robert Park

Senior Vice President and Chief Financial Officer (Principal Financial Officer)

Date: April 30, 2026

EX-99.1

Filename: d16309dex991.htm · Sequence: 2

EX-99.1

Exhibit 99.1

Dolby Laboratories Reports Second Quarter 2026 Financial Results

SAN FRANCISCO, April 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for

the second quarter of fiscal 2026.

“We continue to strengthen our position and create growth opportunities across existing and new business

areas,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “This quarter, we continued to expand our reach especially in sports with events like the Super Bowl, Winter Olympics and T20 Cricket World Cup available in Dolby and

automotive with automakers including BMW and Lexus integrating Dolby into their in-car experiences.”

Second Quarter Fiscal 2026 Financial Highlights

•

Total revenue was $396 million, compared to $370 million for the second quarter of fiscal 2025.

•

GAAP net income was $95 million or $0.99 per diluted share, compared to GAAP net income of $92 million

or $0.94 per diluted share for the second quarter of fiscal 2025. On a non-GAAP basis, second quarter net income was $131 million or $1.37 per diluted share, compared to $131 million or $1.34 per

diluted share for the second quarter of fiscal 2025.

•

Dolby repurchased approximately one million shares of its common stock for approximately $65 million, and

ended the quarter with approximately $142 million of stock repurchase authorization available going forward.

A complete listing of

Dolby’s non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

•

Various sporting events were shown in Dolby Atmos and/or Dolby Vision including the Super Bowl, the 2026 Olympic

Winter Games, and the ICC Men’s T20 Cricket World Cup. Apple TV is streaming Formula One in Dolby Vision.

•

At the 2026 Beijing International Automotive Exhibition (Auto China 2026), BMW and Dolby announced the launch of

Dolby Atmos in the new BMW 7 Series and the new BMW iX3 Long Wheelbase.

•

Douyin, the Chinese version of TikTok, is fully supporting content in Dolby Vision.

•

Hisense, TCL and Philips have announced plans to release a wide range of Dolby Vision 2 enabled TVs globally by

the end of the year, with Peacock and Canal+ committed to delivering content.

•

Sharp and SK Planet joined the Video Distribution Program, bringing the licensor total to 40.

Dividend

Today, Dolby announced a

cash dividend of $0.36 per share of Class A and Class B common stock, payable on May 20, 2026, to stockholders of record as of the close of business on May 12, 2026.

Financial Outlook

Dolby’s financial outlook

relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the

estimates Dolby is providing herein due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain

constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced visibility into Dolby’s future outlook. To the extent possible,

the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are

subject to risks and uncertainties. For more information, see “Forward-Looking Statements” in this press release for a description of certain risks that Dolby faces, and the section captioned “Risk Factors” in its Quarterly

Report on Form 10-Q for the second quarter of fiscal 2026, to be filed on or around the date hereof.

Dolby is providing the following estimates for its third quarter of fiscal 2026:

•

Total revenue is estimated to range from $295 million to $325 million.

•

Licensing revenue is estimated to range from $270 million to $300 million.

•

Gross margins are anticipated to be approximately 86% on a GAAP basis and approximately 88% on a non-GAAP basis.

•

Operating expenses are anticipated to range from $235 million to $245 million on a GAAP basis and from

$200 million to $210 million on a non-GAAP basis.

•

Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.

•

Diluted earnings per share is anticipated to range from $0.19 to $0.34 on a GAAP basis and from $0.56 to $0.71 on

a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2026:

•

Total revenue is expected to range from $1.40 billion to $1.45 billion.

•

Licensing revenue is estimated to range from $1.295 billion to $1.345 billion.

•

Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis.

•

Operating expenses are anticipated to range from $930 million to $950 million on a GAAP basis and from

$780 million to $800 million on a non-GAAP basis.

•

Dolby expects operating margins to be approximately 21% on a GAAP basis and to be approximately 34% on a non-GAAP basis.

•

Effective tax rate is anticipated to be around 23% on a GAAP basis and around 20% on a non-GAAP basis.

•

Diluted earnings per share is anticipated to range from $2.66 to $2.81 on a GAAP basis and from $4.30 to $4.45 on

a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss second quarter fiscal 2026 financial results for Dolby

Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, April 30, 2026.

The conference call can be accessed by registering online at Dolby

Laboratories Q2 Fiscal Year 2026 Financial Results, at which time registrants will receive dial-in information as well as a conference ID.

A live audio webcast of the conference call will be available at http://investor.dolby.com where it will be archived for one year.

Non-GAAP Financial Information

To supplement Dolby’s financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby’s operating results in a manner that focuses on what Dolby’s management believes to be its ongoing business operations and performance.

We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby’s management

regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as

adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense:

Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To

facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible

assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes

these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring

plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be

credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly

correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited

to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin,

non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby’s management believes it is

useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby’s business, including as a means to evaluate period-to-period comparisons. Dolby’s management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation

from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby’s GAAP financial statements as reported in its

US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website,

http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the third quarter of fiscal

2026 and full year fiscal 2026, Dolby’s ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are “forward-looking statements” that

inherently involve substantial risks and uncertainties. These forward-looking statements are based on management’s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those

provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby’s business operations, financial

results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for

such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema

market including adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access

to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and

other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business

internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby’s receipt of royalty reports and payments from its licensees, including

recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby’s ability to develop, maintain, and strengthen relationships with industry participants; Dolby’s

ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in countries that have historically limited recognition and enforcement of

intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby’s ability to increase its revenue streams and to expand its business generally, and to continue to

expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby’s SEC filings and reports, including the risks identified

under the section captioned “Risk Factors” in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed

in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may

be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these

forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby

Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms

the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through

groundbreaking innovations like Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby OptiView.

Dolby, Dolby Atmos, Dolby

Vision, Dolby Cinema, Dolby OptiView, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks

remain the property of their respective owners.

DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts; unaudited)

Fiscal Quarter Ended

Fiscal Year-To-Date Ended

March 27,

2026

March 28,

2025

March 27,

2026

March 28,

2025

Revenue:

Licensing

372,245

346,006

692,016

676,485

Products and services

23,385

23,555

50,320

50,075

Total revenue

395,630

369,561

742,336

726,560

Cost of revenue:

Cost of licensing

24,043

19,685

44,805

40,795

Cost of products and services

20,688

16,152

43,134

35,816

Total cost of revenue

44,731

35,837

87,939

76,611

Gross profit

350,899

333,724

654,397

649,949

Operating expenses:

Research and development

63,651

61,707

132,728

128,345

Sales and marketing

96,163

89,629

187,715

184,028

General and administrative

75,955

70,415

146,198

140,507

Restructuring charges

2,184

4,210

12,650

9,426

Total operating expenses

237,953

225,961

479,291

462,306

Operating income

112,946

107,763

175,106

187,643

Other income/(expense):

Interest income/(expense), net

5,024

3,559

9,142

6,205

Other income, net

1,729

8,928

7,053

12,453

Total other income

6,753

12,487

16,195

18,658

Income before income taxes

119,699

120,250

191,301

206,301

Provision for income taxes

(24,245

)

(28,024

)

(42,166

)

(46,005

)

Net income including noncontrolling interest

95,454

92,226

149,135

160,296

Less: net income attributable to noncontrolling interest

(539

)

(433

)

(893

)

(681

)

Net income attributable to Dolby Laboratories, Inc.

94,915

91,793

148,242

159,615

Net income per share:

Basic

1.00

0.95

1.55

1.66

Diluted

0.99

0.94

1.54

1.64

Weighted-average shares outstanding:

Basic

95,218

96,329

95,342

95,972

Diluted

95,515

97,471

96,273

97,581

DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands; unaudited)

March 27,

2026

September 26,

2025

ASSETS

Current assets:

Cash and cash equivalents

594,282

701,893

Restricted cash

79,523

91,468

Short-term investments

460

703

Accounts receivable, net

391,293

331,096

Contract assets, net

238,924

180,804

Inventories, net

31,929

30,424

Prepaid expenses and other current assets

78,298

51,873

Total current assets

1,414,709

1,388,261

Long-term investments

81,220

80,205

Property, plant, and equipment, net

461,841

470,608

Operating lease

right-of-use assets

44,759

33,204

Goodwill and intangible assets, net

919,378

926,957

Deferred taxes

209,321

214,361

Other non-current assets

118,266

114,164

Total assets

3,249,494

3,227,760

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

20,688

17,840

Accrued liabilities

405,200

369,256

Income taxes payable

8,928

Contract liabilities

38,837

31,382

Operating lease liabilities

9,866

10,384

Total current liabilities

474,606

437,790

Non-current contract liabilities

24,084

29,687

Non-current operating lease liabilities

39,826

28,494

Other non-current liabilities

83,846

99,843

Total liabilities

622,362

595,814

Stockholders’ equity:

Class A common stock

Class B common stock

Retained earnings

2,630,175

2,634,980

Accumulated other comprehensive loss

(12,276

)

(12,517

)

Total stockholders’ equity – Dolby Laboratories, Inc.

2,617,992

2,622,557

Noncontrolling interest

9,140

9,389

Total stockholders’ equity

2,627,132

2,631,946

Total liabilities and stockholders’ equity

3,249,494

3,227,760

DOLBY LABORATORIES, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)

Fiscal Year-To-Date Ended

March 27,

2026

March 28,

2025

Operating activities:

Net income including noncontrolling interest

149,135

160,296

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

48,242

43,899

Stock-based compensation

67,919

66,734

Amortization of operating lease

right-of-use assets

5,417

5,725

Provision for credit losses

3,691

1,967

Deferred income taxes

5,212

(3,741

)

Share of net income of equity method investees, net of cash distributions

(1,933

)

(1,325

)

Other non-cash items affecting net income

(1,741

)

(443

)

Changes in operating assets and liabilities:

Accounts receivable, net

(104,083

)

(420

)

Contract assets, net

(60,474

)

(32,864

)

Inventories

3,853

(1,155

)

Operating lease

right-of-use assets

(17,177

)

(1,608

)

Prepaid expenses and other assets

(33,842

)

26,577

Accounts payable and accrued liabilities

82,873

27,267

Income taxes, net

(6,067

)

5,906

Contract liabilities

7,478

3,282

Operating lease liabilities

11,029

(5,682

)

Other non-current liabilities

(12,227

)

(12,739

)

Net cash provided by operating activities

147,305

281,676

Investing activities:

Proceeds from sales of marketable securities

—

15,911

Proceeds from sale of assets held for sale

—

16,881

Proceeds from sale of intangible assets

6,623

—

Purchases of property, plant, and equipment

(13,690

)

(13,676

)

Business combinations, net of cash and restricted cash acquired, and other related

payments

—

(1,362

)

Purchases of intangible assets

(37,775

)

—

Net cash provided by/(used in) investing activities

(44,842

)

17,754

Financing activities:

Proceeds from issuance of common stock

15,293

26,124

Repurchase of common stock

(135,004

)

(49,999

)

Payment of excise tax on repurchase of common stock

—

(261

)

Payment of cash dividend

(68,674

)

(63,377

)

Distributions to noncontrolling interest

(1,106

)

(981

)

Shares repurchased for tax withholdings on vesting of restricted stock

(32,222

)

(33,950

)

Net cash used in financing activities

(221,713

)

(122,444

)

Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash

(306

)

(4,396

)

Net increase/(decrease) in cash, cash equivalents, and restricted cash

(119,556

)

172,590

Cash, cash equivalents, and restricted cash at beginning of period

793,361

577,752

Cash, cash equivalents, and restricted cash at end of period

673,805

750,342

Licensing Revenue by Market

(unaudited)

The following table presents

the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands, except percentage amounts):

Fiscal Quarter Ended

Fiscal Year-To-Date Ended

Market

March 27, 2026

March 28, 2025

March 27, 2026

March 28, 2025

Broadcast

119,199

94,249

219,462

210,011

Mobile

94,240

100,123

169,189

161,647

40,949

38,140

86,551

87,597

59,463

58,402

88,180

89,658

Other

58,394

55,092

128,634

127,572

Total licensing revenue

372,245

100

346,006

100

692,016

100

676,485

100

GAAP to Non-GAAP Reconciliations

(unaudited)

The following tables present

Dolby’s GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the second quarters of fiscal 2026 and fiscal 2025:

Net income:

Fiscal Quarter Ended

(in thousands)

March 27, 2026

March 28, 2025

GAAP net income attributable to Dolby Laboratories, Inc.

94,915

91,793

Stock-based compensation (1)

30,708

30,664

Amortization of acquisition-related intangibles

(2)

9,713

10,078

Restructuring charges

2,184

4,210

Income tax adjustments

(6,190

)

(6,017

)

Non-GAAP net income attributable to Dolby Laboratories,

Inc.

131,330

130,728

(1) Stock-based compensation included in above line items:

Cost of products and services

424

414

Research and development

9,807

9,043

Sales and marketing

10,216

10,640

General and administrative

10,261

10,567

(2) Amortization of acquisition-related intangibles included in above line items:

Cost of licensing

6,589

6,720

Cost of products and services

772

728

Sales and marketing

356

317

General and administrative

1,555

1,872

Other income, net

441

Diluted earnings per share:

Fiscal Quarter Ended

March 27, 2026

March 28, 2025

GAAP diluted earnings per share

0.99

0.94

Stock-based compensation

0.32

Amortization of acquisition-related intangibles

0.10

Restructuring charges

0.02

0.04

Income tax adjustments

(0.06

)

(0.06

)

Non-GAAP diluted earnings per share

1.37

1.34

Weighted-average shares outstanding - diluted (in thousands)

95,515

97,471

The following tables present a reconciliation between GAAP and non-GAAP versions of the

estimated financial measures for the third quarter of fiscal 2026 and full year fiscal 2026 included in this release:

Gross margin:

Q3 2026

Fiscal 2026

GAAP gross margin

86.0%

88.0%

Stock-based compensation

0.1%

Amortization of acquisition-related intangibles

1.9%

Non-GAAP gross margin

88.0%

90.0%

Operating expenses (in millions):

Q3 2026

Fiscal 2026

GAAP operating expenses (low - high end of range)

235 - $245

930 - $950

Stock-based compensation

(32)

(128)

Amortization of acquisition-related intangibles

(3)

(9)

Restructuring charges

—

(13)

Non-GAAP operating expenses (low - high end of

range)

200 - $210

780 - $800

Operating margin:

Fiscal 2026

GAAP operating margin

21% +/-

Stock-based compensation

Amortization of acquisition-related intangibles

Restructuring charges

Non-GAAP operating margin

34% +/-

Effective tax rate:

Q3 2026

Fiscal 2026

GAAP effective tax rate

23.0%

Stock-based compensation (low - high end of range)

(2%) - 1%

(2%) - 0%

Amortization of acquisition-related intangibles (low - high end of range)

(1%) - 0%

Non-GAAP effective tax rate

21.0%

20.0%

Diluted earnings per share:

Q3 2026

Fiscal 2026

Low

High

Low

High

GAAP diluted earnings per share (low - high end of range)

0.19

0.34

2.66

2.81

Stock-based compensation

0.34

1.34

Amortization of acquisition-related intangibles

0.11

0.43

Restructuring charges

—

0.13

Income tax adjustments

(0.08

)

(0.08

)

(0.26

)

(0.26

)

Non-GAAP diluted earnings per share (low - high end of

range)

0.56

0.71

4.30

4.45

Weighted-average shares outstanding - diluted (in thousands)

95,000

95,700

Investor Contact:

Peter

Goldmacher

415-254-7415

peter.goldmacher@dolby.com

Media Contact:

media@dolby.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Document and Entity Information

Apr. 30, 2026

Cover [Abstract]

Amendment Flag

false

Entity Central Index Key

0001308547

Document Type

8-K

Document Period End Date

Apr. 30, 2026

Entity Registrant Name

DOLBY LABORATORIES, INC.

Entity Incorporation State Country Code

Entity File Number

001-32431

Entity Tax Identification Number

90-0199783

Entity Address, Address Line One

1275 Market Street

Entity Address, City or Town

San Francisco

Entity Address, State or Province

Entity Address, Postal Zip Code

94103-1410

City Area Code

(415)

Local Phone Number

558-0200

Written Communications

false

Soliciting Material

false

Pre Commencement Tender Offer

false

Pre Commencement Issuer Tender Offer

false

Security 12b Title

Class A common stock, $0.001 par value

Trading Symbol

DLB

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration